Site (ICD) | Inpatient Register RA cohort* | Early arthritis RA cohort | TNF antagonist RA cohort | |||
---|---|---|---|---|---|---|
No | SIR (95% CI) | No | SIR (95% CI) | No | SIR (95% CI) | |
Follow up from 1990 (or entry into cohort, if later) until 31 December 2003. Relative risk estimated comparing each cohort with the general Swedish population and adjusting for age, sex, and calendar period. | ||||||
*Cancers occurring during first 365 days after entry into cohort are excluded; †total solid exceeds sum of site-specific cancers, as only major sites are displayed. | ||||||
All solid† (140–199) | 3379 | 1.05 (1.01 to 1.08) | 138 | 1.1 (0.9 to 1.3) | 67 | 0.9 (0.7 to 1.2) |
Oropharyngeal (140–148) | 54 | 1.02 (0.76 to 1.33) | 1 | 0.5 (0.0 to 2.7) | 0 | 0.0 (0.0 to 3.0) |
Oesophagus (150) | 36 | 1.32 (0.93 to 1.83) | 3 | 2.8 (0.6 to 8.2) | 0 | 0.0 (0.0 to 7.0) |
Stomach (151) | 102 | 1.10 (0.89 to 1.33) | 2 | 0.7 (0.08 to 2.5) | 0 | 0.0 (0.0 to 2.7) |
Small intestine (152) | 20 | 1.22 (0.75 to 1.89) | 1 | 1.7 (0.04 to 9.4) | 0 | 0.0 (0.0 to 11) |
Colorectal (153+154) | 342 | 0.74 (0.66 to 0.82) | 18 | 1.1 (0.7 to 1.8) | 10 | 1.2 (0.6 to 2.3) |
Hepatobiliary (155–156) | 103 | 1.15 (0.94 to 1.40) | 5 | 1.9 (0.6 to 4.3) | 1 | 0.7 (0.0 to 4.1) |
Pancreas (157) | 79 | 0.93 (0.74 to 1.16) | 3 | 1.1 (0.2 to 3.2) | 0 | 0.0 (0.0 to 2.4) |
Larynx (161) | 13 | 1.19 (0.63 to 2.04) | 0 | 0.0 (0.0 to 7.5) | 1 | 4.0 (0.1 to 22) |
Lung (162) | 330 | 1.48 (1.33 to 1.65) | 23 | 2.4 (1.5 to 3.6) | 10 | 1.8 (0.9 to 3.3) |
Breast (170) | 471 | 0.83 (0.76 to 0.91) | 13 | 0.6 (0.3 to 0.1.0) | 8 | 0.4 (0.2 to 0.9) |
Cervix (171) | 33 | 1.03 (0.71 to 1.45) | 1 | 0.8 (0.02 to 4.3) | 1 | 1.0 (0.0 to 5.8) |
Uterine corpus (172) | 84 | 0.60 (0.48 to 0.75) | 1 | 0.2 (0.01 to 1.1) | 2 | 0.6 (0.0 to 2.1) |
Prostate (177) | 390 | 0.98 (0.89 to 1.09) | 32 | 1.6 (1.1 to 2.3) | 8 | 1.0 (0.4 to 2.0) |
Testis (178) | 1 | 0.60 (0.02 to 3.37) | 1 | 7.9 (0.2 to 44) | 0 | 0.0 (0.0 to 34) |
Kidney (180) | 118 | 1.46 (1.21 to 1.75) | 2 | 0.7 (0.08 to 2.5) | 1 | 0.6 (0.0 to 3.5) |
Urinary bladder (181) | 179 | 1.14 (0.98 to 1.32) | 8 | 1.3 (0.6 to 2.6) | 1 | 0.4 (0.0 to 2.0) |
Melanoma (190) | 120 | 1.19 (0.99 to 1.42) | 4 | 0.9 (0.2 to 2.2) | 1 | 0.3 (0.0 to 1.8) |
Non-melanoma skin (191) | 374 | 1.66 (1.50 to 1.84) | 5 | 0.7 (0.2 to 1.6) | 11 | 3.6 (1.8 to 6.5) |
Brain (193) | 78 | 1.12 (0.89 to 1.40) | 0 | 0.00 (0.0 to 1.2) | 4 | 1.8 (0.5 to 4.6) |
Connective tissue (197) | 28 | 1.42 (0.95 to 2.06) | 0 | 0.00 (0.0 to 5.1) | 0 | 0.0 (0.0 to 9.2) |